BONE-MARROW TRANSPLANTATION FOR LEUKEMIA AFTER CONDITIONING WITH BUSULFAN AND CYCLOPHOSPHAMIDE - BONE-MARROW MORPHOLOGY IN THE EARLY RECOVERY PHASE

被引:0
|
作者
CAO, DC
TUTSCHKA, PJ
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The bone marrow morphology of fifty patients with leukemia was analyzed before and two weeks after allogeneic bone marrow transplantation and compared to that of ten normal, healthy control subjects. Conditioning of the marrow graft recipients had been carried out with a combination of 16 mg / kg of Busulfan and 120 mg / kg of cyclophosphamide. The bone marrow at two weeks after transplant showed characteristic features that were unique for this clinical setting. Regenerative precursor cells with a distinct morphology commonly formed clusters or islands. Although mixed, multilinear islands were seen; the majority of islands were unilinear with a homogeneous cell content. These hematopoietic colonies were in direct proximity to degenerated cells of presumed host origin. No damage to the microenvironment was seen, the most characteristic finding being large, uniform, unilocular fat cells in close proximity to regenerative precursor cells. These morphologic changes are indicative of a complete and persistent marrow engraftment.
引用
收藏
页码:267 / 276
页数:10
相关论文
共 50 条
  • [31] CONDITIONING REGIMENS FOR BONE-MARROW TRANSPLANTATION
    STORB, R
    BONE MARROW TRANSPLANTATION, 1993, 12 : S16 - S18
  • [32] EOSINOPHILIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION USING THE BUSULFAN AND CYCLOPHOSPHAMIDE PREPARATIVE REGIMEN
    KALAYCIOGLU, ME
    BOLWELL, BJ
    BONE MARROW TRANSPLANTATION, 1994, 14 (01) : 113 - 115
  • [33] HISTOPATHOLOGY OF BONE-MARROW RECONSTITUTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    VANDENBERG, H
    KLUIN, PM
    ZWAAN, FE
    VOSSEN, JM
    HISTOPATHOLOGY, 1989, 15 (04) : 363 - 373
  • [34] PHARMACOLOGY OF CICLOSPORIN IN THE BONE-MARROW AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SONNEVELD, P
    KOKENBERG, E
    SIZOO, W
    HAGENBEEK, A
    VANDERSTEUIJT, K
    LOWENBERG, B
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1986, 8 (06) : 307 - 307
  • [35] ENDOTHELIN IN THE EARLY PHASE OF BONE-MARROW TRANSPLANTATION
    TSAKIRIS, DA
    LUESCHER, TF
    LOEFFLER, BM
    MARBET, GA
    SPECK, B
    GRATWOHL, A
    TRANSPLANTATION, 1994, 57 (02) : 300 - 301
  • [36] TREATMENT OF HIGH-RISK LEUKEMIA WITH BUSULFAN, CYCLOPHOSPHAMIDE, ETOPOSIDE AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    ALESSANDRINO, EP
    BERNASCONI, P
    BONFICHI, M
    CALDERA, D
    BONI, M
    BELLANTUONO, I
    BIAGGI, G
    BERNASCONI, C
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1132 - 1132
  • [37] ALLOGENEIC BONE-MARROW TRANSPLANTATION AFTER HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE IN PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA
    GELLER, RB
    SARAL, R
    PIANTADOSI, S
    ZAHURAK, M
    VOGELSANG, GB
    WINGARD, JR
    AMBINDER, RF
    BESCHORNER, WB
    BRAINE, HG
    BURNS, WH
    HESS, AD
    JONES, RJ
    MAY, WS
    ROWLEY, SD
    WAGNER, JE
    YEAGER, AM
    SANTOS, GW
    BLOOD, 1989, 73 (08) : 2209 - 2218
  • [38] BONE-MARROW PURGING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    GRIBBEN, JG
    NADLER, LM
    LEUKEMIA & LYMPHOMA, 1993, 11 : 141 - 148
  • [39] BUSULFAN, CYCLOPHOSPHAMIDE, AND MELPHALAN AS CONDITIONING THERAPY IN ALLOGENEIC BONE-MARROW TRANSPLANTS FOR ACUTE LYMPHOBLASTIC-LEUKEMIA
    RUSSELL, S
    VOWELS, M
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (01) : 183 - 183
  • [40] ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA
    KOLB, HJ
    RECENT RESULTS IN CANCER RESEARCH, 1984, 93 : 269 - 289